Skip to main content
SpringerLink
Log in

Clinicopathologic Features of Hepatocellular Carcinoma Patients with Compensated Cirrhosis Surviving More than 10 Years after Curative Hepatectomy

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to clarify the clinicopathologic features of hepatocellular carcinoma (HCC) patients with compensated cirrhosis surviving more than 10 years after initial hepatectomy.

Study Design

Among 250 patients who underwent hepatectomy for HCC between 1987 and 1994 at our institute, 145 patients who had Child-Pugh class A liver function and who underwent curative resection were included in this study. Clinicopathologic factors in 10-year survivors and patients who died within 10 years (nonsurvivors) were compared, and the prognostic factors affecting survival were identified.

Results

There were 29 patients who survived for more than 10 years after initial hepatectomy, and 9 of those patients survived without cancer recurrence. The 3-, 5-, and 10-year survival rates were 76.2%, 53.0%, and 26.9% respectively. The corresponding disease-free survival rates were 43.1%, 25.7%, and 9.9% respectively. In multivariate analysis, liver fibrosis grade F0–2, female gender, ICG-R15 value of less than 15%, and absence of microscopic vascular invasion were favorable independent factors associated with 10-year survival. Disease-free interval after initial hepatectomy in 10-year survivors with recurrence was significantly longer than that in nonsurvivors with recurrence, 5.1 and 1.9 years respectively (P = 0.0004). The number of intrahepatic recurrent nodules in 10-year survivors tended to be fewer than that in nonsurvivors.

Conclusions

Based on the results of our study, liver fibrosis grade F0–2, female gender, ICG-R15 value of less than 15% and absence of microscopic vascular invasion at initial hepatectomy might be biologically favorable conditions for long-term survival. Close follow-up as well as multimodal treatment could contribute to prolongation of survival in such patients, even if HCC recurrence develops.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1.
Figure 2.

Similar content being viewed by others

References

  1. Itamoto T, Katayama K, Nakahara H, et al. Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease. Br J Surg 2003;90:23–28

    Article  PubMed  CAS  Google Scholar 

  2. Itamoto T, Nakahara H, Tashiro H, et al. Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis. Am J Surg 2005;189:167–172

    Article  PubMed  Google Scholar 

  3. Nakahara H, Itamoto T, Katayama K, et al. Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B. World J Surg 2005;29:734–738

    Article  PubMed  Google Scholar 

  4. Shirabe K, Shimada M, Kajiyama K, et al. Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 1998;83:2312–3216

    Article  PubMed  CAS  Google Scholar 

  5. Shimada K, Sano T, Sakamoto Y, et al. A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 2005;104:1939–1947

    Article  PubMed  Google Scholar 

  6. Ichida F, Tsuji T, Omata M, et al. New Inuyama classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996;6:112–119

    Article  Google Scholar 

  7. Fukuda S, Itamoto T, Nakahara H, et al. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 2005;52:1163–1167

    PubMed  Google Scholar 

  8. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996;83:1219–1222

    Article  PubMed  CAS  Google Scholar 

  9. Nagao T, Inoue S, Yoshimi F, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990;211:28–33

    Article  PubMed  CAS  Google Scholar 

  10. Shimada M, Takenaka K, Taguchi K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998;227:80–95

    Article  PubMed  CAS  Google Scholar 

  11. Nagasue N, Yu L, Yukaya H, et al. Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg 1995;82:542–547

    PubMed  CAS  Google Scholar 

  12. De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol 2002;193:59–63

    Article  PubMed  Google Scholar 

  13. Imamura H, Sano K, Sugawara Y, et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005;12:16–22

    Article  PubMed  Google Scholar 

  14. Bilimoria MM, Lauwers GY, Doherty DA, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001;136:528–535

    Article  PubMed  CAS  Google Scholar 

  15. Wayne JD, Lauwers GY, Ikai I, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002;235:722–730

    Article  PubMed  Google Scholar 

  16. Ko S, Kanehiro H, Hisanaga M, et al. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 2002;89:57–62

    Article  PubMed  CAS  Google Scholar 

  17. Yoshida H, Shiratori Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 1999;131:174–181

    PubMed  CAS  Google Scholar 

  18. Takenaka K, Yamamoto K, Taketomi A, et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995;22:20–24

    Article  PubMed  CAS  Google Scholar 

  19. Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B, C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996;24:307–310

    Article  PubMed  CAS  Google Scholar 

  20. Ikeda K, Arase Y, Saitoh S, et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—a prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000;32:228–232

    Article  PubMed  CAS  Google Scholar 

  21. Kubo S, Nishiguchi S, Hirohashi K, et al. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 2002;89:418–422

    Article  PubMed  CAS  Google Scholar 

  22. Nagasue N, Ono T, Yamanoi A, et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 2001;88:515–522

    Article  PubMed  CAS  Google Scholar 

  23. Nagashima I, Hamada C, Naruse K, et al. Surgical resection for small hepatocellular carcinoma. Surgery 1996;119:40–45

    Article  PubMed  CAS  Google Scholar 

  24. Lise M, Bacchetti S, Da Pian P, et al. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 1998;82:1028–1036

    Article  PubMed  CAS  Google Scholar 

  25. Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500–507

    Article  PubMed  CAS  Google Scholar 

  26. Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003;238:703–710

    Article  PubMed  Google Scholar 

  27. Poon RT, Fan ST, Lo CM, et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999;229:216–222

    Article  PubMed  CAS  Google Scholar 

  28. Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004;198:356–365

    Article  PubMed  Google Scholar 

  29. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699

    Article  PubMed  CAS  Google Scholar 

  30. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998;27:1572–1577

    Article  PubMed  CAS  Google Scholar 

  31. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999;19:311–322

    Article  PubMed  CAS  Google Scholar 

  32. Bigourdan JM, Jaeck D, Meyer N, et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003;9:513–520

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, 1-2-3, Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan

    Saburo Fukuda MD, Toshiyuki Itamoto MD, Hironobu Amano MD, Toshihiko Kohashi MD, Hideki Ohdan MD, Hirotaka Tashiro MD & Toshimasa Asahara MD

Authors
  1. Saburo Fukuda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiyuki Itamoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hironobu Amano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshihiko Kohashi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hideki Ohdan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hirotaka Tashiro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Toshimasa Asahara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saburo Fukuda MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukuda, S., Itamoto, T., Amano, H. et al. Clinicopathologic Features of Hepatocellular Carcinoma Patients with Compensated Cirrhosis Surviving More than 10 Years after Curative Hepatectomy. World J. Surg. 31, 345–352 (2007). https://doi.org/10.1007/s00268-006-0513-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-006-0513-7

Keywords

Search

Navigation